TAK-536CCB
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-536CCB, covering 2014-02-26 to 2014-02-26. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension. [Phase 2, Phase 3]